(Press-News.org) Brussels, 8 November 2023 – New international research on the economic burden of urinary incontinence reveals that the cost of continence care will reach an estimated €69.1 billion in 2023. These costs include the impact of incontinence on individuals’ health, the costs of medical consultations and products such as continence pads, incontinence-related absenteeism at work, nursing home admissions, and the environmental impact of incontinence care. If no action is taken to support continence health, the economic burden could rise by 25% in 2030, to €86.7 billion. This economic burden becomes considerably higher when including caregiver costs.
Some 55-60 million Europeans suffer from problems with continence health (the ability to control the bladder and bowel). However, the health, economic and environmental burden attributed to urinary incontinence (UI) is largely unknown. The European Association of Urology together with 22 stakeholders have initiated a campaign, Urge to Act, that aims to achieve substantial change in policies relating to incontinence across Europe. This campaign will be kicked off on 8 November in Brussels at the first European Continence Health Summit.
At the Summit, a socio-economic report, the first of its kind, presents the burden of UI in the European Union countries (EU) in terms of the prevalence, healthcare costs and the environmental impact from 2023 to 2030. The report demonstrates that across all EU countries, the estimated economic burden of UI was €69.1 billion in 2023. The economic burden for females was four times higher than males, and the economic burden increases by 16% when accounting for the informal support provided by caregivers. Concerning waste disposal of continence pads, the cost of incinerating (burning the pads) was marginally lower than recycling. However, the carbon footprint of recycling is significantly lower.
The economic analysis presented in this report estimates the economic burden of UI could increase by 25% if no action is taken, to €86.7 billion in 2030. Without better awareness, prevention, treatment and resource-wise use of continence technologies in cases when this often chronic condition cannot be cured, the economic burden will most likely increase.
To present solutions, the manifesto for policy reform on transforming EU Continence Health is launched in parallel. The manifesto, endorsed by 23 organisations, calls for concrete policy changes to face the challenges posed by the report and makes 10 high-level recommendations to European and national policymakers to recognise the importance of patient-centred continence care and to promote a holistic understanding of the intricate links between continence health and healthy ageing, women’s health, as well as disease areas like cancer, mental health, neurological problems and several other comorbidities such as obesity. This will require increased funding for continence health research.
Professor Philip Van Kerrebroeck, co-chairman of the Policy Office of the European Association of Urology and leading expert in the field of incontinence, says: “Continence problems are felt across gender, age, and socio-economic backgrounds, and can result in a serious negative impact on individuals’ quality of life. Physical, psychosocial and economic consequences for patients and their carers are a barrier to full participation in society. Optimal continence health should be a reality for everyone.”
Since the risk of continence problems often correlates with conditions that develop or intensify as people age, it is predicted that these problems will increase, as the European population is ageing at a rapid pace. Health professionals and informal caregivers are making every effort within the existing constraints of different health systems. However, current systems are not yet fully adapted to support continence care. Policies and laws in both EU Member States and non-member European countries tend to neglect continence care despite its prevalence, serious nature, and availability of solutions.
Van Kerrebroeck: “It is time to take action and transform this neglected issue to address the continence health challenge Europe is facing. In our Urge to Act campaign we would like to make policymakers aware that there are many ways to improve continence health, through increased prevention, better care, access to supportive interventions including treatment, and more inclusive environments. Much more should be done to reduce the direct expenses, the burden on patients, their carers, and on society.”
END
The annual economic burden of urinary incontinence could reach €87 billion in 2030 if no action is taken
First Continence Health Summit in Brussels gives stark warning on costs related to continence care and presents a manifesto for policy reform
2023-11-08
ELSE PRESS RELEASES FROM THIS DATE:
Researchers say AI model accurately identifies, predicts joint damage in hand X-rays
2023-11-07
ATLANTA — New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that a deep learning system could accurately identify and predict joint space narrowing and erosions in hand radiographs of patients with rheumatoid arthritis (RA) (Abstract #0745).
Radiographs are the most commonly used imaging technique for detecting and monitoring RA in the hand. Radiologists frequently use the well-validated Sharp/van der Heidje (SvH) method to evaluate joint space ...
Study finds acute calcium pyrophosphate deposition arthritis doubles fracture risk
2023-11-07
ATLANTA - Researchers will present the first-ever study of fractures and calcium pyrophosphate deposition disease at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting. They report a doubled risk of fractures in patients with acute calcium pyrophosphate crystal arthritis compared to those without the disease (Abstract #0235).
Calcium pyrophosphate deposition (CPPD) disease occurs when calcium pyrophosphate (CPP) crystals form near cartilage cells, and sometimes leads to joint inflammation, pain, and swelling. It has often been called pseudogout because ...
Education key to curbing antimicrobial resistance in cats
2023-11-07
ITHACA, N.Y. -- Better education for cat owners, more communication from veterinarians, increased drug choices and cheaper, rapid diagnostic tools can help improve antimicrobial use in cats, which has important implications for rising antimicrobial resistance in animals and humans, according to two new papers by Cornell researchers.
Antimicrobial resistance threatens up to 10 million human lives a year and may cost the global economy trillions of dollars, with resistant pathogens moving easily between humans and animals, according to the papers’ authors.
In one paper, “Divergent Veterinarian and Cat ...
New compound shows early promise for treatment of Lou Gehrig’s disease in preclinical models
2023-11-07
In science, a simple but thorough observation can kick-start the most surprising findings. Researchers at the Hollings Cancer Center at the Medical University of South Carolina noticed that mice lacking a protein of interest in cancer research were showing visible signs of abnormal motor functions as they aged, including loss of coordination and strength. The team showed that that lack of this protein resulted in the accumulation of damaged mitochondria that affected motor function. Treating these mice with a drug that triggered the destruction of damaged mitochondria restored their motor ...
Diverse task force develops new quality measures to improve lupus care by 2030
2023-11-07
ATLANTA — Leaders of a project to develop and implement equitable new quality measures for lupus care by the end of the decade will present their work at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting (Abstract #1899).
Systemic lupus erythematosus (SLE, lupus) is an autoimmune disease marked by adaptive immune system activation, formation of autoantibodies, and systemic inflammation affecting organ systems throughout the body. Lupus disproportionately affects women and people of color, who are more likely to have severe ...
Study finds low anti-Ro titers are not associated with fetal heart block
2023-11-07
ATLANTA - New research from an ongoing study that will be presented at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that pregnant women with very low titers of anti-Ro antibodies are at minimal to no risk of fetal atrioventricular (AV) block, a serious disorder affecting the heart’s electrical system.
After birth, fetal AV block requires lifelong pacemaker treatment or cardiac transplantation and may be fatal. However, pregnant patients with higher titer antibodies seem to be at greatest risk at risk ...
Study finds hydroxychloroquine lowers risk of nonalcoholic fatty liver disease in rheumatoid arthritis patients
2023-11-07
ATLANTA - New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that treating rheumatoid arthritis with hydroxychloroquine (HCQ) reduced the risk of nonalcoholic fatty liver disease, especially in women and men who are 50 years old and younger (Abstract #0396).
Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory disease marked by chronic joint inflammation leading to joint damage and loss of function. It can also affect tissues and organs outside the joints, including (but not limited to) the eyes, ...
Study shows saliva gland abnormalities in Sjögren's worsens over time
2023-11-07
ATLANTA - New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that ultrasound-detected salivary gland abnormalities in primary Sjögren's become more severe over time and that the slow-to-progress disease likely starts long before it is first detected (Abstract #1371).
Sjögren's disease also known as Primary Sjögren’s syndrome, is a systemic autoimmune disorder. It is marked by inflammation of the lacrimal and salivary glands, leading to chronic dry eyes and mouth. Fatigue is common, ...
Study finds positive antiphospholipid antibodies raises cardiovascular disease risk in patients with systemic lupus erythematosus
2023-11-07
ATLANTA — New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, describes a link between positive antiphospholipid antibodies and an increased risk of future cardiovascular disease in patients with systemic lupus erythematosus (SLE) (Abstract #0552).
Antiphospholipid antibodies (aPLs) are autoantibodies directed against phospholipid-binding proteins. In antiphospholipid syndrome, they are associated with heart attack, stroke, and pulmonary embolism, and with miscarriage and stillbirth during pregnancy.
People with SLE also have a greatly increased risk ...
Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome
2023-11-07
ATLANTA - New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, found that JAK inhibitors (JAKi) and tocilizumab elicited better response rates in VEXAS syndrome compared to other targeted therapies (Abstract #L03).
VEXAS syndrome is a rare and often fatal autoimmune condition caused by a mutation in the UBA1 gene. It is marked by widespread inflammation leading to a range of symptoms that affect the skin, lungs, blood vessels and joints. The name is an acronym for disease characteristics: vacuoles in bone marrow, E1 enzyme (the enzyme encoded by the UBA1 gene), ...
LAST 30 PRESS RELEASES:
Counting the carbon cost of E-waste
Stanford research teams tackle environmental impacts of U.S. policy
Grant to expand self-cloning crop technology for Indian farmers
Atlantic nurse sharks show faster growth patterns in Biscayne Bay than nearby Bimini, Bahamas
Tests uncover unexpected humpback sensitivity to high-frequency noise
Paracetamol and ibuprofen safe in first year of life
Major US tobacco brands flouting platform + federal policies to restrict young people’s access to their content on Instagram
Sleeping without pillows may lower harmful high internal eye pressure in people with glaucoma
More than just ‘daydreaming’ – dissociation is the mind’s survival tactic
Researchers identify genetic blueprint of mania in bipolar disorder
Delivery of magnetic energy to the brain is a cost-effective treatment option for patients with depression, finds a new study
Pennington Biomedical’s Dr. Candida Rebello secures $3. 7 million NIH grant to study muscle retention in older adults
Badged up for success
FAU leaps ahead as state’s first university to host an onsite quantum computer
International team led by HonorHealth Research Institute and U of A develop 3D chip platform for laboratory testing in cancer research
Clinical trial seeks improved survival for head and neck cancer patients
COVID-19 viral fragments shown to target and kill specific immune cells in UCLA-led study
Research findings may lead to earlier diagnoses of genetic disorder
In polar regions, microbes are influencing climate change as frozen ecosystems thaw, McGill review finds
The Vertebrate Genome Laboratory at The Rockefeller University receives support from Google.org for AI science research
Scientists develop first gene-editing treatment for skin conditions
New cancer-killing material developed by Oregon State University nanomedicine researchers
Physicists predict significant growth for cadmium telluride photovoltaics
Purdue team announces new therapeutic target for breast cancer
‘Nudging’ both patients and providers boosts flu vaccine numbers
How do nature and nurture shape our immune cells?
Speeding, hard braking reduced in insurance plans that base rates on driving behavior, offer rewards
Shared process underlies oral cancer pain and opioid tolerance
Claiming your business page on review platforms can have unintended effects on customer reviews, study shows
Inflammation and autoimmune-like dysfunction may play a role in heart failure
[Press-News.org] The annual economic burden of urinary incontinence could reach €87 billion in 2030 if no action is takenFirst Continence Health Summit in Brussels gives stark warning on costs related to continence care and presents a manifesto for policy reform

